Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Biomarkers for Early Detection and Prognosis of Heart Failure
Author(s): Moza A Alzaabi , Amin Abdelsalam , Majid Alhammadi , et al Added: 1 year ago

Heart Failure
Biomarkers for Congestion in Heart Failure
Author(s): Antonio Luca Maria Parlati , Cristina Madaudo , Vincenzo Nuzzi , et al Added: 1 year ago

Heart Failure
Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches
Author(s): Giulia Tamburrini , Celia de Cobos García , Teresa López Fernández Added: 7 months ago

CV Disease in Special Populations

Heart Failure
RDW Prognostic Marker in HF and Predictor for Iron Replacement Responsivene
Author(s): Artemio García-Escobar , Rosa Lázaro-García , Javier Goicolea-Ruigómez , et al Added: 1 year ago

Heart Failure
The Art and Science of Congestion Diagnosis and Management in Heart Failure
Author(s): Josip A Borovac , Dino Miric Added: 3 months ago

Heart Failure
Job title: Associate Director of Medical and Scientific Affairs
Hans-Peter Brunner-La Rocca
Research Area(s) / Expertise:
Hans-Peter Brunner-La Rocca is a heart failure cardiologist, trained in Switzerland and has been working in the Academic Hospital Maastricht, in the Netherlands for 10 years. He is head of the Heart Failure Clinic and head of the division of Structural Heart Diseases. His main research interests are biomarkers and eHealth to achieve personalised treatment in heart failure. He was the trial leader… View more
Research Area(s) / Expertise: Job title: Professor of Medicine
Dr Eileen O’Meara is Professor at the Department of Medicine at the University of Montrealand practices cardiology at the Montreal Heart Institute. Dr O’Meara pursued a Fellowship in Heart Failure at the Western Infirmary & Glasgow Royal Infirmary in the UK, and another in Stress Echocardiography and Tissue Doppler at Hôpital Européen Georges Pompidou in Paris. Her research focuses on… View more
HFSA 25: 96-week Analysis from FOREST-HCM
Author(s): Ahmad Masri Added: 6 months ago
HFSA 25 - Aficamten found to significantly improve NYHA and KCCQ-CSS scores in new 96-week data from FOREST-HCM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss findings from the FOREST-HCM trial, examining the sustained safety and efficacy of aficamten in patients with symptomatic nonobstructive hypertrophic cardiomyopathy.This phase 2 open-label study followed 34… View more

Heart Failure
Valentina Puntmann
Dr Valentina Puntmann is Deputy Head of Department and senior clinical investigator with subspecialty interest in mutimodality cardiovascular imaging and conduct of clinical trials using imaging biomarkers. Her research projects focus on the development of novel imaging biomarkers for the detection of cardiovascular injury, supporting risk stratification, prevention and therapy. She is chief… View more